4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029902
President & CEO sold 36,529 shares at $3.95 ($144,290)
- President & CEO acquired 68,450 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2022-05-15 | Grant or award | +68,450 | 657,470 | D | ||
| ROBIN HOWARD W President & CEO | 2022-05-16 | Sale | −36,529 | $3.95 | $144,290 | 620,941 | D |
| Open-market sales · 36,529 sh · avg $3.95 · $144,290 | |||||||
Loading xslF345X03/doc4.xml…